Dermatology and Inflammatory Skin Disease
GALENpharma GmbH focuses on clinical research in plaque psoriasis, with interest in the management of chronic stable plaque-type disease and its visible inflammatory features.
- Plaque psoriasis
- Chronic stable plaque-type psoriasis
- Topical dermatologic therapy
The sponsor’s research activity is centred on assessing treatment effects on erythema, induration, and scaling in cutaneous inflammatory disease.
Topical Corticosteroid Treatment
The funded trial landscape includes evaluation of a topical corticosteroid formulation in comparison with an active comparator and a vehicle, reflecting interest in locally applied anti-inflammatory therapy.
- Mometasone furoate
- Cutaneous emulsion
- Comparator product
This area is directed toward clinical assessment of skin-directed treatment options for reducing inflammatory signs in psoriasis.
Therapeutic Efficacy in Skin Inflammation
Research activity is concentrated on measuring improvement in Total Sign Score, with attention to the combined burden of erythema, induration, and scaling as indicators of treatment response.
- Total Sign Score
- Erythema
- Scaling
The sponsor’s clinical interest lies in therapies intended to improve the appearance and severity of psoriatic lesions through local anti-inflammatory action.
